Supportive Care in Severe and Very Severe Aplastic Anemia

Read full text Summarise with VIRAT
Authors: Britta Höchsmann, Mahmoud Deeb Aljurf, Hubert Schrezenmeier, Shaykhah Alotaibi
Cited by: 0
References: 103

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Optimal management of aplastic anemia is not only limited to immediate diagnosis, early decision-making, and timely initiation of major treatment strategies such as immunosuppression or stem cell transplantation, but also involves supportive treatment as a crucial aspect of patient care. Patients are at risk of cytopenia-related complications throughout the disease course. This chapter summarizes the optimal infection control practices, current recommendations for prevention and early treatment of bacterial, fungal, and viral infections, transfusion strategies, and iron chelation approaches. Many recommendations for aplastic anemia are not based on randomized studies specific to this disease but are extrapolated from conditions with similar severity of cytopenia. Prevention and management of complications, including hemorrhage, infection, alloimmunization to blood products, and iron overload, significantly impact prognosis and should be carefully observed in clinical practice. More controlled studies on supportive care in this rare disease are needed.

Fields of Study & Subjects

Neutropenia and Cancer Infections Blood disorders and treatments Hematological disorders and diagnostics

Publication details

Journal / source
Springer eBooks
Pages
99–113
Publication date
25 March 2026
Language
EN
Document type
Book chapter